Mr. Christopher R. Donoho

Christopher R. Donoho, III is a partner with Hogan Lovells US LLP in New York and global head of its Business Restructuring and Insolvency practice group. He is experienced in domestic and cross-border private-equity portfolio company restructurings, bondholder group representations and distressed M&A. He has played a leading role on numerous award-winning deals, including advising the Kodak Pension Plan in the Eastman Kodak Company chapter 11 case (which won the Turnaround Management Association?s 2014 Mega Turnaround of the Year Award, where he received an individual award for his contributions), representing Orexigen Therapeutics in its chapter 11 proceedings and successfully negotiating a court-approved § 363 sale of Orexigen?s assets to Nalproprion Pharmaceuticals (winner of The M&A Advisor?s 2018 Turnaround Award for Healthcare/Life Sciences Deal of the Year (Under $500m)), and representing the unsecured creditors? committees in the Abengoa chapter 11 cases, having confirmed plans of reorganization delivering substantial value to unsecured creditors and now is pursuing additional recoveries for the liquidating trustees (which won The M&A Advisor?s 2017 Turnaround Award for § 363 Sale of the Year (Over $250m - $500m)). From 2015-19, Mr. Donoho served as the office administrative partner of the firm?s New York office. He received his A.B. from Brown University in 1991 and his J.D. from Vanderbilt University in 1994.